The FDA should adopt a policy on imported devices that reduces risk at each point in a product's life cycle, said Timothy Ulatowski, director of compliance at FDA's Center for Devices and Radiological Health. The agency is set to issue draft guidelines that will detail standards for third-party certification programs aimed at products under its control, as well as good-importer practices, Ulatowski said.

Full Story:

Related Summaries